Vanguard Fiduciary Trust
MDGL icon

Vanguard Fiduciary Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History

Vanguard Fiduciary Trust’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.3M Sell
121,583
-6,496
-5% -$3.33M 0.01% 722
2026
Q1 		$67M Buy
+128,079
New +$61.2M 0.02% 674

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's MDGL Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Madrigal Pharmaceuticals (MDGL) stake by 5.1% in Q2 2026, selling an estimated $3.33M and leaving 121,583 shares worth $65.3M. The position accounts for 0.01% of the portfolio, ranked #722.

Vanguard Fiduciary Trust first reported a position in MDGL in Q1 2026 and has held it in 2 quarters since. The position peaked at $67M in Q1 2026. 410 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Vanguard Fiduciary Trust held 121,583 shares of Madrigal Pharmaceuticals worth $65.3M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 6,496 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $3.33M.
  • Madrigal Pharmaceuticals made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #722 holding.
  • Vanguard Fiduciary Trust first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Madrigal Pharmaceuticals position peaked at $67M in Q1 2026.
  • 410 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.